Back
FTI Consulting Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
55
FCN
FTI Consulting
Last Price:
225.14
Seasonality Move:
7.3%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
54.42
Seasonality Move:
11.04%
Buy
55
FTI Consulting (FCN)
is a Buy
Is FTI Consulting a Buy, Sell or Hold?
- The current FTI Consulting [FCN] share price is $222.63. The Score for FCN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- FCN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCN Stock Price Chart
What is FTI Consulting's stock price today?
-
The FTI Consulting share price today is $222.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCN is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
FCN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 51.81 | Buy |
Chaikin Money Flow: | -80252 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (220.23 - 224.91) | Buy |
Bollinger Bands (100): | (213.85 - 224.53) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -159819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.64 - 50.28) | Buy |
Bollinger Bands (100): | (39.46 - 48.56) | Buy |
FCN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 221.15 | Buy |
20-day SMA: | 222.45 | Buy |
50-day SMA: | 222.41 | Buy |
200-day SMA: | 211.77 | Buy |
8-day EMA: | 222.17 | Buy |
20-day EMA: | 221.97 | Buy |
50-day EMA: | 221.03 | Buy |
200-day EMA: | 212.32 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.55 | Buy |
20-day SMA: | 48.38 | Buy |
50-day SMA: | 47.86 | Buy |
200-day SMA: | 43.39 | Buy |
8-day EMA: | 50.8 | Buy |
20-day EMA: | 49.06 | Buy |
50-day EMA: | 47.17 | Buy |
200-day EMA: | 41.51 | Buy |
FTI Consulting Earnings Growth & FCN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.55 per share, an increase this year of $1.43 per share, and an increase next year of $0.91 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
FTI Consulting Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |